US Patent 8252923 Peptidomimetic protease inhibitors
Patent 8252923 was granted and assigned to Vertex Pharmaceuticals on August, 2012 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8252923 Peptidomimetic protease inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.